Principles of Kinase Allosteric Inhibition and Pocket Validation-Reference-Cited by-同舟云学术

Principles of Kinase Allosteric Inhibition and Pocket Validation

Published:2022-03-21 Issue:7 Volume:65 Page:5288-5299
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Pan Yue¹,Mader Mary M.¹^ORCID

Affiliation:

1. Relay Therapeutics, 399 Binney Street, Cambridge, Massachusetts 02139, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00073

Reference71 articles.

1. Kinase drug discovery 20 years after imatinib: progress and future directions

2. Avoiding or Co-Opting ATP Inhibition: Overview of Type III, IV, V, and VI Kinase Inhibitors

3. Medicinal Chemistry Strategies for the Development of Kinase Inhibitors Targeting Point Mutations

4. New Promise and Opportunities for Allosteric Kinase Inhibitors

5. BristolMyersSquibb. Q3 2021 Results. BristolMyersSquibb, 2021. https://www.bms.com/investors/events-and-presentations.html (accessed November 5, 2021).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Development of CDK2 Inhibitors as Anticancer Drugs: An Update (2015–2023);Pharmaceutical Fronts;2024-09-03

2. Design and synthesis of novel fluorene derivatives as inhibitors of pyruvate dehydrogenase kinase;Bioorganic & Medicinal Chemistry Letters;2024-09

3. Targeting cyclin-dependent kinases: From pocket specificity to drug selectivity;European Journal of Medicinal Chemistry;2024-09

4. BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib;Blood;2024-08-08

5. Gaining Insights into Key Structural Hotspots within the Allosteric Binding Pockets of Protein Kinases;International Journal of Molecular Sciences;2024-04-26